Join the club for FREE to access the whole archive and other member benefits.

Ivan Morgunov

CEO at Unlimited Bio and Founder of Longaevus Technologies

Building a rejuvenation combo with gene therapies at Unlimited Bio—the most advanced solution today.

Ivan developed an interest in longevity about 7 years ago, and since then has been searching for the right team that would possess deep understanding of the field and share his views on the multidirectional approach when it comes to ageing reversal.

Visit website: https://longaevus.tech/team/ivan-morgunov

 ivan.morgunov.35

 ivanmorgunov

 EvanMorgun

See also

Unlimited Bio

First preventive gene therapy VEGF (Vascular Endothelial Growth Factor)

Details last updated 29-Aug-2025

Ivan Morgunov News

Longevity funding innovation prize: shaping the future of longevity research

Longevity funding innovation prize: shaping the future of longevity research

Live Forever Club - 01-Nov-2023

A $20,000 prize for innovative approaches to increase longevity sector funding

Mentioned in this Resource

Longaevus Technologies

UK-based research organisation focused on diverse longevity pathways

Ivan Morgunov is also referenced in the following:

Inside the Offshore Clinics Developing Gene Therapy to Fight Aging

Optispan podcast episode - Unlimited Bio’s Ivan Morgunov & Anna Vakhrusheva: gene therapies in SEZs

Longevity State Conference 2024

13-May-2024

Conference about longevity, its social changes and aging organised by Vitalism Foundation (Cofrentes, Spain)